Abstract
This paper describes a new technique for prophylactic treatment of recurrent mandibular dislocation using injection of botulinum toxin A (BtA) into the lateral pterygoid muscles. BtA temporarily weakens muscles by blocking acetylcholine release, and thus operates through a principle different from established treatments such as joint sclerosant therapy, eminectomy or Dautry's procedure. The patient suffered recurrent mandibular dislocations caused by tardive dystonia. We injected 75 mu BtA percutaneously into each lateral pterygoid muscle under electromyographic guidance. No further dislocations occurred over the subsequent 10 months, and follow-up continues. There were no immediate or delayed side effects. More experience is required before this becomes an established treatment. BtA is usually given in outpatients, and is less invasive or destructive than previous options. It may not be suitable if dislocation is due to lax ligaments or weak muscles. Operators must be aware that other BtA preparations require a different dose
Similar content being viewed by others
Article PDF
Rights and permissions
About this article
Cite this article
Moore, A., Wood, G. Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J 183, 415–417 (1997). https://doi.org/10.1038/sj.bdj.4809523
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bdj.4809523
This article is cited by
-
Ultrasound-guided lateral pterygoid muscle botulinum toxin: an injection for recurrent temporomandibular joint dislocation in a brain injury patient
Oral and Maxillofacial Surgery (2022)
-
Botulinum Toxin in the Treatment of Muscle Specific Oro-Facial Pain: A Literature Review
Journal of Maxillofacial and Oral Surgery (2015)
-
Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection
Clinical Oral Investigations (2003)
-
Recurrent dislocation of the temporomandibular joints: a diagnostic and treatment problem
British Dental Journal (2002)